SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
38 hedge funds and large institutions have $128M invested in Sinovac Biotech, Ltd in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $30K
Holders
38
Holding in Top 10
1
Calls
–
Puts
$30K
Top Buyers
| 1 | +$865K | |
| 2 | +$294K | |
| 3 | +$198K | |
| 4 |
Two Sigma Investments
New York
|
+$146K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$113K |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$668K | |
| 3 | -$627K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$380K |
| 5 |
Morgan Stanley
New York
|
-$278K |